当前位置: X-MOL 学术Adv. Healthcare Mater. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Tailored Approaches in Drug Development and Diagnostics: From Molecular Design to Biological Model Systems
Advanced Healthcare Materials ( IF 10.0 ) Pub Date : 2017-09-11 , DOI: 10.1002/adhm.201700258
Cecilia Sahlgren 1, 2, 3 , Annika Meinander 1 , Hongbo Zhang 4 , Fang Cheng 1 , Maren Preis 4 , Chunlin Xu 5 , Tiina A. Salminen 6 , Diana Toivola 1, 7 , Daniel Abankwa 3 , Ari Rosling 8 , Didem Şen Karaman 4 , Outi M. H. Salo-Ahen 4, 6 , Ronald Österbacka 9 , John E. Eriksson 1, 2 , Stefan Willför 5 , Ion Petre 10 , Jouko Peltonen 11 , Reko Leino 12 , Mark Johnson 6 , Jessica Rosenholm 4 , Niklas Sandler 4
Affiliation  

Approaches to increase the efficiency in developing drugs and diagnostics tools, including new drug delivery and diagnostic technologies, are needed for improved diagnosis and treatment of major diseases and health problems such as cancer, inflammatory diseases, chronic wounds, and antibiotic resistance. Development within several areas of research ranging from computational sciences, material sciences, bioengineering to biomedical sciences and bioimaging is needed to realize innovative drug development and diagnostic (DDD) approaches. Here, an overview of recent progresses within key areas that can provide customizable solutions to improve processes and the approaches taken within DDD is provided. Due to the broadness of the area, unfortunately all relevant aspects such as pharmacokinetics of bioactive molecules and delivery systems cannot be covered. Tailored approaches within (i) bioinformatics and computer‐aided drug design, (ii) nanotechnology, (iii) novel materials and technologies for drug delivery and diagnostic systems, and (iv) disease models to predict safety and efficacy of medicines under development are focused on. Current developments and challenges ahead are discussed. The broad scope reflects the multidisciplinary nature of the field of DDD and aims to highlight the convergence of biological, pharmaceutical, and medical disciplines needed to meet the societal challenges of the 21st century.

中文翻译:

药物开发和诊断中的量身定制方法:从分子设计到生物模型系统

需要改善药物和诊断工具开发效率的方法,包括新的药物输送和诊断技术,以改善对重大疾病和健康问题(如癌症,炎性疾病,慢性伤口和抗生素耐药性)的诊断和治疗。为了实现创新的药物开发和诊断(DDD)方法,需要从计算科学,材料科学,生物工程学到生物医学科学和生物影像学等多个研究领域进行开发。在此,概述了关键领域中的最新进展,这些进展可以提供可定制的解决方案来改善流程,并在DDD中采用了各种方法。由于区域广,不幸的是,不能涵盖所有相关方面,例如生物活性分子的药代动力学和递送系统。(i)生物信息学和计算机辅助药物设计,(ii)纳米技术,(iii)用于药物输送和诊断系统的新型材料和技术以及(iv)预测正在开发的药物的安全性和有效性的疾病模型的量身定制方法上。讨论了当前的发展和未来的挑战。广泛的范围反映了DDD领域的多学科性质,旨在突出满足21世纪社会挑战所需的生物学,药学和医学学科的融合。(iii)用于药物输送和诊断系统的新型材料和技术,以及(iv)预测正在开发的药物的安全性和有效性的疾病模型。讨论了当前的发展和未来的挑战。广泛的范围反映了DDD领域的多学科性质,旨在突出满足21世纪社会挑战所需的生物学,药学和医学学科的融合。(iii)用于药物输送和诊断系统的新型材料和技术,以及(iv)预测正在开发的药物的安全性和有效性的疾病模型。讨论了当前的发展和未来的挑战。广泛的范围反映了DDD领域的多学科性质,旨在突出满足21世纪社会挑战所需的生物学,药学和医学学科的融合。
更新日期:2017-09-11
down
wechat
bug